Concepedia

Renée Aspiotis

RA

Statistics

Publications

13

Citations

1K

H-Index

12

Active since

1996

Affiliations

Merck Canada Inc. (Canada)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Renée Aspiotis is an author at Merck Canada Inc. (Canada) specializing in drug discovery, pharmacology, and medicinal chemistry.

Publications per year

1996–2011

13

Publications

13

Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte

Richard S. Hotchkiss, K. Chang, Paul E. Swanson et al. · Nature Immunology · 2000 · 527 citations

, , +14

Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886

Denis Riendeau, Renée Aspiotis, Diane Ethier et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 142 citations · Full text

, , +8

Reducing the Peptidyl Features of Caspase-3 Inhibitors:  A Structural Analysis

Joseph W. Becker, J. Rotonda, S.M. Soisson et al. · Journal of Medicinal Chemistry · 2004 · 86 citations · Full text

, , +17

Diastereoselective Intermolecular [4 + 3] Cycloadditions via an Extended Transition State:  A Route to Enantiomerically Enriched Cycloadducts

Mark Lautens, Renée Aspiotis, John Colucci · Journal of the American Chemical Society · 1996 · 54 citations

, , +11

Discovery of MK-0952, a selective PDE4 inhibitor for the treatment of long-term memory loss and mild cognitive impairment

Michel Gallant, Renée Aspiotis, Stephen H. Day et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 44 citations · Full text

, , +11

1–5 of 13